U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Avioq HTLV-I/II Microelisa System
  1. Vaccines, Blood & Biologics

Avioq HTLV-I/II Microelisa System

STN:  BL 125394
Proper Name: Human T-Lymphotropic Virus Types I & II (HTLV-I and HTLV-II/Enzyme Immuno Assay (EIA)/Lysate
Tradename: Avioq HTLV-I/II Microelisa System
Manufacturer: Avioq, Inc.
Indication:  

  • The Avioq HTLV I/II assay is a qualitative ELISA for the detection of antibodies to HTLV-I and/or HTLV-II in human serum or plasma from volunteer blood donors, other living donors, and cadaveric specimens on the ORTHO® Summit System (OSS), and for manual use as an aid in clinical diagnosis of HTLV-I or HTLV-II infection and related diseases. It is not intended for use on cord blood specimens.

Product Information

Supporting Documents

 

Back to Top